Traynor Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$7.92M |
| 2 |
Vale
VALE
|
+$4M |
| 3 |
Amazon
AMZN
|
+$3.69M |
| 4 |
Apple
AAPL
|
+$3.46M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.43M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$2.93M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$2.49M |
| 4 |
Boeing
BA
|
+$1.72M |
| 5 |
QuidelOrtho
QDEL
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.29% |
| 2 | Consumer Discretionary | 14.66% |
| 3 | Communication Services | 13.06% |
| 4 | Healthcare | 6.45% |
| 5 | Financials | 4.55% |
Similar funds
Traynor Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Traynor Capital Management held 236 positions worth $845M, up 16% from $730M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Traynor Capital Management deployed $33.4M of net new capital in Q4 2021, opening 36 new positions and adding to 90 existing holdings. Its largest new stake was Vale: 301,199 shares worth $4.22M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was iShares S&P 500 Value ETF, an estimated $2.49M trimmed.
- Traynor Capital Management's largest Q4 2021 buy was Vale: 301,199 shares worth $4.22M.
- Traynor Capital Management added most to Advanced Micro Devices in Q4 2021, an estimated $7.92M increase.
- Traynor Capital Management's biggest Q4 2021 reduction was iShares S&P 500 Value ETF, cutting an estimated $2.49M.
- Traynor Capital Management fully exited Biogen in Q4 2021, selling an estimated $6.43M.
- Traynor Capital Management's ten largest holdings make up 52% of its $845M portfolio in Q4 2021.
- Traynor Capital Management opened 36 new positions and closed 13 in Q4 2021.
- Traynor Capital Management's portfolio value rose 16% quarter-over-quarter to $845M.
Based on Traynor Capital Management's 13F filing for Q4 2021, filed 1 Feb 2022.